Colgate-Palmolive (NYSE:CL) Stock Position Decreased by AMI Asset Management Corp

AMI Asset Management Corp decreased its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 396,588 shares of the company's stock after selling 8,616 shares during the period. Colgate-Palmolive accounts for 1.9% of AMI Asset Management Corp's investment portfolio, making the stock its 24th biggest position. AMI Asset Management Corp's holdings in Colgate-Palmolive were worth $36,054,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter valued at $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive in the third quarter valued at $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at about $64,000. True Wealth Design LLC grew its stake in Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company's stock worth $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC increased its position in shares of Colgate-Palmolive by 93.4% in the third quarter. Continuum Advisory LLC now owns 762 shares of the company's stock worth $79,000 after acquiring an additional 368 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.37% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of CL traded up $0.08 during trading hours on Tuesday, reaching $88.27. 5,012,739 shares of the company's stock traded hands, compared to its average volume of 4,876,979. The firm has a market capitalization of $72.12 billion, a price-to-earnings ratio of 25.29, a P/E/G ratio of 3.62 and a beta of 0.44. The business's fifty day simple moving average is $92.13 and its two-hundred day simple moving average is $97.71. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.27%. Colgate-Palmolive's dividend payout ratio (DPR) is 57.31%.

Analyst Ratings Changes

Several research firms have commented on CL. TD Cowen cut their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating for the company in a research note on Thursday, January 16th. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research note on Friday. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. Finally, Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating on the stock in a research note on Friday. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of "Hold" and an average price target of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.